The potential for normal tissue dose reduction with neoadjuvant hormonal therapy in conformal treatment planning for stage C prostate cancer

Farley E. Yang, George T Y Chen, Paul Ray, Florin Vaida, Parvathi Chiru, Russell J Hamilton, Danny Spelbring, Milagros Abellera, Srinivasan Vijayakumar

Research output: Contribution to journalArticle

50 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)1009-1017
Number of pages9
JournalInternational Journal of Radiation Oncology Biology Physics
Volume33
Issue number5
DOIs
StatePublished - Dec 1 1995
Externally publishedYes

Fingerprint

Hormonal Antineoplastic Agents
Radiotherapy Dosage
Goserelin
Flutamide
rectum
Neoadjuvant Therapy
bladder
Adjuvant Chemotherapy
Rectum
planning
Prostate
therapy
Prostatic Neoplasms
Urinary Bladder
Adenocarcinoma
Retrospective Studies
cancer
dosage
Therapeutics

Keywords

  • Conformal therapy
  • Hormonal cytoreduction
  • Neoadjuvant hormonal therapy
  • Prostate cancer

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation

Cite this

The potential for normal tissue dose reduction with neoadjuvant hormonal therapy in conformal treatment planning for stage C prostate cancer. / Yang, Farley E.; Chen, George T Y; Ray, Paul; Vaida, Florin; Chiru, Parvathi; Hamilton, Russell J; Spelbring, Danny; Abellera, Milagros; Vijayakumar, Srinivasan.

In: International Journal of Radiation Oncology Biology Physics, Vol. 33, No. 5, 01.12.1995, p. 1009-1017.

Research output: Contribution to journalArticle

Yang, Farley E. ; Chen, George T Y ; Ray, Paul ; Vaida, Florin ; Chiru, Parvathi ; Hamilton, Russell J ; Spelbring, Danny ; Abellera, Milagros ; Vijayakumar, Srinivasan. / The potential for normal tissue dose reduction with neoadjuvant hormonal therapy in conformal treatment planning for stage C prostate cancer. In: International Journal of Radiation Oncology Biology Physics. 1995 ; Vol. 33, No. 5. pp. 1009-1017.
@article{25a3f1ade5164dd7b45c473ffbb7db96,
title = "The potential for normal tissue dose reduction with neoadjuvant hormonal therapy in conformal treatment planning for stage C prostate cancer",
keywords = "Conformal therapy, Hormonal cytoreduction, Neoadjuvant hormonal therapy, Prostate cancer",
author = "Yang, {Farley E.} and Chen, {George T Y} and Paul Ray and Florin Vaida and Parvathi Chiru and Hamilton, {Russell J} and Danny Spelbring and Milagros Abellera and Srinivasan Vijayakumar",
year = "1995",
month = "12",
day = "1",
doi = "10.1016/0360-3016(95)02064-0",
language = "English (US)",
volume = "33",
pages = "1009--1017",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - The potential for normal tissue dose reduction with neoadjuvant hormonal therapy in conformal treatment planning for stage C prostate cancer

AU - Yang, Farley E.

AU - Chen, George T Y

AU - Ray, Paul

AU - Vaida, Florin

AU - Chiru, Parvathi

AU - Hamilton, Russell J

AU - Spelbring, Danny

AU - Abellera, Milagros

AU - Vijayakumar, Srinivasan

PY - 1995/12/1

Y1 - 1995/12/1

KW - Conformal therapy

KW - Hormonal cytoreduction

KW - Neoadjuvant hormonal therapy

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=0028802574&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028802574&partnerID=8YFLogxK

U2 - 10.1016/0360-3016(95)02064-0

DO - 10.1016/0360-3016(95)02064-0

M3 - Article

VL - 33

SP - 1009

EP - 1017

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 5

ER -